In the afternoon of August 8, 2019, Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library met with Dr. Xiaobo Wang, General Manager of Acea Biosciences, Inc. – a part of Agilent Technologies in San Diego, California, U.S.A. They discussed latest advances in label-free cell functionality monitoring technologies and instruments.